Lauro Moretto, Emeritus President of the Brazilian Academy of Pharmaceutical Sciences and former Executive Vice-President of Sindusfarma provides insights into the main changes that have impacted Brazil’s pharmaceutical field over the past few years as well as his vision to propel the development of pharmaceutical sciences in the country.
What would you highlight as the most significant changes that have happened in Brazil’s pharmaceutical industry since our last interview, in 2011?
"One of the most significant transformations relates to the regulatory area, with Brazil undoubtedly moving closer to international standards over the past five years."
